BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16479533)

  • 1. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver.
    Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y
    J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice.
    Kanbe T; Murai R; Mukoyama T; Murawaki Y; Hashiguchi K; Yoshida Y; Tsuchiya H; Kurimasa A; Harada K; Yashima K; Nishimuki E; Shabana N; Kishimoto Y; Kojyo H; Miura K; Murawaki Y; Kawasaki H; Shiota G
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1517-25. PubMed ID: 16735026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
    Tahara Y; Ido A; Yamamoto S; Miyata Y; Uto H; Hori T; Hayashi K; Tsubouchi H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):146-51. PubMed ID: 12954797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model.
    Oh K; Iimuro Y; Takeuchi M; Kaneda Y; Iwasaki T; Terada N; Matsumoto T; Nakanishi K; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G729-35. PubMed ID: 15550554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
    Setoyama H; Ido A; Numata M; Moriuchi A; Yamaji N; Tamai T; Funakawa K; Fujita H; Sakiyama T; Uto H; Oketani M; Tsubouchi H
    Life Sci; 2011 Aug; 89(7-8):269-75. PubMed ID: 21763320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
    Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice.
    Mukoyama T; Kanbe T; Murai R; Murawaki Y; Shimomura T; Hashiguchi K; Saeki T; Ichiba M; Yoshida Y; Tanabe N; Kurimasa A; Harada K; Yashima K; Hisatome I; Ito H; Murawaki Y; Shiota G
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1217-24. PubMed ID: 15766556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
    Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
    Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.
    Matsuki A; Yamamoto S; Nakagami H; Aoki M; Tamai K; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Biochem Biophys Res Commun; 2004 Feb; 315(1):59-65. PubMed ID: 15013425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
    Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
    J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.
    Hogaboam CM; Vallance BA; Kumar A; Addison CL; Graham FL; Gauldie J; Collins SM
    J Clin Invest; 1997 Dec; 100(11):2766-76. PubMed ID: 9389741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).
    Nakanishi K; Uenoyama M; Tomita N; Morishita R; Kaneda Y; Ogihara T; Matsumoto K; Nakamura T; Maruta A; Matsuyama S; Kawai T; Aurues T; Hayashi T; Ikeda T
    Am J Pathol; 2002 Nov; 161(5):1761-72. PubMed ID: 12414523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model.
    Liu HJ; Wu CT; Duan HF; Wu B; Lu ZZ; Wang L
    Surgery; 2006 Sep; 140(3):441-7. PubMed ID: 16934607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.
    Dai C; Yang J; Bastacky S; Xia J; Li Y; Liu Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J; Dai C; Liu Y
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 gene therapy prevents TNBS-induced colitis.
    Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
    Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.